Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer
出版年份 2012 全文链接
标题
Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer
作者
关键词
-
出版物
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 61, Issue 10, Pages 1849-1856
出版商
Springer Nature
发表日期
2012-03-28
DOI
10.1007/s00262-012-1231-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes
- (2011) Fangfang Liu et al. BREAST CANCER RESEARCH AND TREATMENT
- Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer
- (2011) Sylvain Ladoire et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Prognostic and Predictive Impact of Intra- and Peritumoral Immune Infiltrates
- (2011) W. H. Fridman et al. CANCER RESEARCH
- Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer
- (2011) Marie Tosolini et al. CANCER RESEARCH
- Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy
- (2011) N. Halama et al. CANCER RESEARCH
- In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival
- (2011) Sylvain Ladoire et al. JOURNAL OF PATHOLOGY
- Immune parameters affecting the efficacy of chemotherapeutic regimens
- (2011) Laurence Zitvogel et al. Nature Reviews Clinical Oncology
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents
- (2011) Naganari Ohkura et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Intratumoral lymphocyte density in serous ovarian carcinoma is superior to ERCC1 expression for predicting response to platinum-based therapy
- (2011) Hans Bösmüller et al. VIRCHOWS ARCHIV
- The Predictive Value of HLA Class I Tumor Cell Expression and Presence of Intratumoral Tregs for Chemotherapy in Patients with Early Breast Cancer
- (2010) E. M. de Kruijf et al. CLINICAL CANCER RESEARCH
- T regulatory cells in cancer: recent advances and therapeutic potential
- (2010) Eyad Elkord et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Tumor-Infiltrating Foxp3+ Regulatory T Cells are Correlated with Cyclooxygenase-2 Expression and are Associated with Recurrence in Resected Non-small Cell Lung Cancer
- (2010) Katsuhiko Shimizu et al. Journal of Thoracic Oncology
- Intratumoral CD8+ T/FOXP3+ cell ratio is a predictive marker for survival in patients with colorectal cancer
- (2009) Hiroyuki Suzuki et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2009) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune infiltration in human tumors: a prognostic factor that should not be ignored
- (2009) F Pagès et al. ONCOGENE
- Th1/Th2 balance: an important indicator of efficacy for intra-arterial chemotherapy
- (2008) Hidenari Nagai et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cancer treatment: the combination of vaccination with other therapies
- (2008) Mads Hald Andersen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Predictive value of MMP-7 expression for response to chemotherapy and survival in patients with non-small cell lung cancer
- (2008) Hui Liu et al. CANCER SCIENCE
- Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non-Small Cell Lung Cancer
- (2008) K. I. Al-Shibli et al. CLINICAL CANCER RESEARCH
- Tumor-specific regulatory T cells in cancer patients
- (2008) Sytse J. Piersma et al. HUMAN IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started